|
FZD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00079999998393E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.7445999994935E-07 |
| Normal-vs-Stage2 |
2.164600E-01 |
| Normal-vs-Stage3 |
3.167600E-02 |
| Normal-vs-Stage4 |
4.023800E-02 |
| Stage1-vs-Stage2 |
3.549200E-01 |
| Stage1-vs-Stage3 |
2.638600E-01 |
| Stage1-vs-Stage4 |
6.393800E-01 |
| Stage2-vs-Stage3 |
8.066600E-01 |
| Stage2-vs-Stage4 |
3.870600E-01 |
| Stage3-vs-Stage4 |
3.741400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33599999957634E-07 |
| Normal-vs-AfricanAmerican |
1.182160E-03 |
| Normal-vs-Asian |
4.160900E-04 |
| Caucasian-vs-AfricanAmerican |
4.207400E-01 |
| Caucasian-vs-Asian |
4.681600E-01 |
| AfricanAmerican-vs-Asian |
3.530800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.61879995466785E-09 |
| Normal-vs-Female |
5.549200E-01 |
| Male-vs-Female |
9.69800000000243E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.049090E-04 |
| Normal-vs-Extreme_Weight |
2.71800000284372E-08 |
| Normal-vs-Obese |
6.322000E-03 |
| Normal-vs-Extreme_Obese |
1.05689999996272E-06 |
| Normal_Weight-vs-Extreme_Weight |
3.180600E-01 |
| Normal_Weight-vs-Obese |
3.377400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.425600E-02 |
| Extreme_Weight-vs-Obese |
3.917600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.357200E-01 |
| Obese-vs-Extreme_Obese |
5.905900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.821800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.639000E-04 |
| Normal-vs-Age(61-80Yrs) |
5.64610003195298E-09 |
| Normal-vs-Age(81-100Yrs) |
1.55534999999318E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.733600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.431600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.525900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.018800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.710400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.543800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.66010000482942E-08 |
| Normal-VS-Type2 PRCC |
4.07200000385188E-08 |
| Normal-VS-KIRP CIMP |
1.194430E-01 |
| Normal-VS-Unclassified PRCC |
3.937100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.330000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.320170E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.388000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.038120E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.198600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.126100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.95589999999468E-05 |
| Normal-vs-N1 |
4.061400E-01 |
| Normal-vs-N2 |
4.367500E-02 |
| N0-vs-N1 |
1.581570E-01 |
| N0-vs-N2 |
8.079400E-01 |
| N1-vs-N2 |
6.414600E-01 |
|
|
